Skip to main content

Kratom Facts

Opioid; Stimulant; Indole alkaloid; Mu-opioid receptor partial agonist

Description

Kratom (Mitragyna speciosa Korth., Rubiaceae) is a tropical tree native to Southeast Asia whose leaves contain over 40 alkaloids. Its dominant constituent, mitragynine, activates both opioid and stimulant pathways in the brain. At low doses this produces alertness and energy; at higher doses, sedation and pain suppression dominate.

Subjective effects include stimulation, mood elevation, pain relief, sedation, and euphoria — shifting from sociable energy at lower doses to opioid-like warmth and cognitive slowing at higher doses.[1] The defining quality is a dose-dependent inversion absent from conventional stimulants or opioids, though preparation type and alkaloid concentration shape the experience considerably.[2]

Prolonged use carries significant opioid-type physical dependence risk, and kratom is a documented cause of drug-induced liver injury.[3][4] The highest-risk pattern is combining kratom with opioids or sedatives — additive opioid signaling can slow breathing to a dangerous or fatal degree.[5][6]

Dose and duration

No dose or duration recorded for any route.

Body and dependence

Acute toxicity
Low
Chronic toxicity
Moderate
Physical dependence
High
Psychological dependence
High
Withdrawal
Moderate
Compulsive redosing
Moderate

Tolerance

Builds
Moderate
Fully resets after
10 days
Carries over to
opioids

Who shouldn't take it

Absolute
Pre-existing liver disease; Pregnancy and lactation; Concurrent opioid use; Concurrent CNS depressants
Relative
Respiratory compromise; History of psychosis; Renal impairment; CYP3A4 substrates with narrow therapeutic index

Combinations65 recorded

Lethal (5)
Alcohol; GBL; GHB; Ketamine; Tramadol
Dangerous (23)
Alpha-2 adrenergic receptor antagonist; Anticholinergics; Benzodiazepines, Barbiturates; Gabapentin, Pregabalin; GHB, Baclofen; Opioids; Poppers (Alkyl nitrites); Poppers, Nitrates; Antipsychotics; Atypical antipsychotics; Benzodiazepines; DXM; GHB, GBL; Ibogaine; Ketamine, DXM, PCP; Local anesthetics; MAOIs; MDMA, MDA; NDRIs (Wellbutrin); SNRIs; SSRIs; Synthetic cannabinoids; Salvia, Ibogaine
Caution (28)
See full page: psychedex.org/substances/kratom
Not graded (9)
Not listed never means safe.

Seek help immediately if

  • Unresponsive / can't be woken, even to a firm sternal rub
  • Slow, shallow, or stopped breathing
  • Pinpoint pupils
  • Blue/grey lips, fingertips, or skin (cyanosis)
  • Limp body; pale, clammy skin
  • Choking or gurgling sounds ("death rattle")
  • Slow, erratic, or absent pulse

What to do

  1. Try to wake them — shout their name, firm sternal rub
  2. Call emergency services immediately
  3. Administer naloxone if available
  4. Give rescue breaths (or CPR if there is no pulse)
  5. Place them in the recovery position
  6. Stay with them; re-dose naloxone every 2–3 minutes if there is no response
Reversal agent
Naloxone (Narcan) — opioid antagonist. May require repeated doses; its effect can wear off before the opioid does.

With prompt naloxone and rescue breathing, reversal is usually rapid. Because naloxone can wear off before the opioid — especially with long-acting opioids (methadone) or high-potency ones (fentanyl) — a period of monitoring is needed even after the person revives.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r2 · Not medical advice

References

  1. [1]
    ^Smith KE, Rogers JM, Dunn KE, Grundmann O, McCurdy CR, Schriefer D, Epstein DH (2022) Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories — Frontiers in Pharmacology doi:10.3389/fphar.2022.765917
  2. [2]
    ^Sharma A, Kamble SH, Leon F et al. (2019) Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry — Drug Testing and Analysis doi:10.1002/dta.2604
  3. [3]
    ^Singh D, Muller CP, Vicknasingam BK (2014) Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users — Drug and Alcohol Dependence doi:10.1016/j.drugalcdep.2014.03.017
  4. [4]
    ^Schimmel J, Dart RC (2020) Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review — Drugs doi:10.1007/s40265-019-01242-6
  5. [5]
    ^Shi T, Shea JL (2024) A case of fatal overdose involving both hydromorphone and kratom — Journal of Forensic Sciences doi:10.1111/1556-4029.15394
  6. [6]
    ^Kronstrand R, Roman M, Thelander G, Eriksson A (2011) Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton — Journal of Analytical Toxicology PMID:21513619
Print version
Report an issue